ArticleJournal of family medicine and primary care2023

Utilizing peripheral blood inflammatory biomarker (PBIB) to predict response to systemic therapy in patients with breast cancer.

Atlal AbusanadPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.